Grigoris Gerotziafas: Join Our Workshop on Advancing Guideline Adoption in Cancer-Associated Thrombosis at ISTH 2026
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn:
”Join us at ISTH 2026 in Paris for a high-level international partnered workshop
From Evidence to Implementation: Advancing Guideline Adoption in Cancer-Associated Thrombosis
10 July 2026 | 15:00–19:30 | Paris
Despite major advances in evidence and international recommendations, the implementation of guidelines for ‘cancer-associated thrombosis (CAT)’ prevention and treatment remains inconsistent across healthcare systems.
This interactive workshop is organized by CaVITE (CRSA, INSERM U938, Sorbonne University) in collaboration with ICTHIC and will bring together
international experts, clinicians, researchers, healthcare professionals, policymakers, and key stakeholders to discuss practical solutions for translating evidence and guidelines into real-world practice.
The roundtable aims to initiate a ‘Roadmap for improving CAT guideline implementation worldwide’.
We warmly invite physicians, fellows, nurses, pharmacists, researchers, policymakers, and healthcare stakeholders to join this important discussion.
Please share within your professional networks.”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 13:46Danny Gaskin: Recognising Iron Deficiency Before Anaemia
-
Nov 11, 2026, 13:46James P. Crowley: Newborn Vitamin K Refusal a 347% Surge in Life-Threatening Bleeding
-
Nov 11, 2026, 13:42Manideepa Maji: IV Iron Safety in Heart Failure
-
Nov 11, 2026, 13:36Wilson Andrés Vásconez Samaniego: NGS-Based Genomic Profiling Before Gene Therapy for Hemoglobinopathies
-
Nov 11, 2026, 13:34Mathieu Jackson: WFH Opens Registration for 2027 Comprehensive Care Summit
-
Nov 11, 2026, 13:29Maia Meier: Recognising Bleeding Disorders Through the 7-2-1 Rule
-
Nov 11, 2026, 13:17Kiran Rajeev T: Elsevier Releases New Practical Handbook on Transfusion Medicine
-
Nov 11, 2026, 13:01Reza Shojaei: FDA Approval Marks Milestone for Factor XIa-Targeted Therapy
-
Nov 11, 2026, 11:35Paulus Kirchhof: Oral Anticoagulation in Atrial Fibrillation After Intracranial Hemorrhage